More articles from Volume 45, Issue 3, 2016
Effect of low potassium concentration on cadmium induced epileptiform activity of leech retzius neurons
Application of sepsis-related organ failure assessment score in the intensive care units
Examination of myeloperoxidase activity, as an indicator of inflammation in obese participants with metabolic syndrome
The influence of head posture on the vertical dimension and the growth of facial skeleton
Levels of interleukin IL-6 in gingival fluid during orthodontic tooth movement: Children vs. adult
Examination of myeloperoxidase activity, as an indicator of inflammation in obese participants with metabolic syndrome
,
Tamara Matic
,
Dragana Puhalo-Sladoje
,
Bojana Kisic
,
Goran Trajkovic
,
Ilija Dragojevic
Dijana Miric
Abstract
Keywords
References
1.
Lee O, Lee D, Lee S, Kim Y. Associations between Physical Activity and Obesity Defined by Waist-To-Height Ratio and Body Mass Index in the Korean Population. PLoS One. 2016;(7):158245.
2.
Lee B, Lee J. Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance. Biochim Biophys Acta. 2014;(3):446–62.
3.
Srikanthan K, Feyh A, Visweshwar H, Shapiro J, Sodhi K. Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population. Int J Med Sci. 2016;(1):25–38.
4.
Nicholls S, Hazen S. Myeloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2005;(6):1102–11.
5.
Pattison D, Davies M, Hawkins C. Reactions and reactivity of myeloperoxidase-derived oxidants: differential biological effects of hypochlorous and hypothiocyanous acids. Free Radic Res. 2012;(8):975–95.
6.
Cai H, Griendling K, Harrison D. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci. 2003;(9):471–8.
7.
Zhang R, Brennan M, Shen Z, Macpherson J, Schmitt D, Molenda C, et al. Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation. J Biol Chem. 2002;(48):46116–22.
8.
Nauseef W. Contributions of myeloperoxidase to proinflammatory events: more than an antimicrobial system. Int J Hematol. 2001;(2):125–33.
9.
Tremblay A, Morrissette H, Gagné J, Bergeron J, Gagné C, Couture P. Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population. Clin Biochem. 2004;(9):785–90.
10.
Dypbukt J, Bishop C, Brooks W, Thong B, Eriksson H, Kettle A. A sensitive and selective assay for chloramine production by myeloperoxidase. Free Radic Biol Med. 2005;(11):1468–77.
11.
Alberti K, Zimmet P, Shaw J. Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;(5):469–80.
12.
Harford K, Reynolds C, Mcgillicuddy F, Roche H. Fats, inflammation and insulin resistance: insights to the role of macrophage and T-cell accumulation in adipose tissue. Proc Nutr Soc. 2011;(4):408–17.
13.
Galic S, Oakhill J, Steinberg G. Adipose tissue as an endocrine organ. Mol Cell Endocrinol. 2010;(2):129–39.
14.
Wisse B. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol. 2004;(11):2792–800.
15.
Zur B, Look M, Holdenrieder S, Stoffel-Wagner B. Elevated plasma myeloperoxidase concentration in adults with obesity. Clin Chim Acta. 2011;(19–20):1891–2.
16.
Andrade V, Petruceli E, Belo V, Andrade-Fernandes C, Russi C, Bosco C, et al. Evaluation of plasmatic MMP-8, MMP-9, TIMP-1 and MPO levels in obese and lean women. Clin Biochem. 2012;(6):412–5.
17.
Olza J, Aguilera C, Gil-Campos M, Leis R, Bueno G, Martínez-Jiménez M, et al. Myeloperoxidase is an early biomarker of inflammation and cardiovascular risk in prepubertal obese children. Diabetes Care. 2012;(11):2373–6.
18.
Choi Y, Yoon Y, Lee KY, Hien T, Kang K, Kim KC, et al. Uric acid induces endothelial dysfunction by vascular insulin resistance associated with the impairment of nitric oxide synthesis. FASEB J. 2014;3197–204.
19.
Klop B, Elte J, Cabezas M. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients. 2013;(4):1218–40.
20.
Howard B, Ruotolo G, Robbins D. Obesity and dyslipidemia. Endocrinol Metab Clin North Am. 2003;855–67.
21.
Dullaart R, Annema W, Tio R, Tietge U. The HDL anti-inflammatory function is impaired in myocardial infarction and may predict new cardiac events independent of HDL cholesterol. Clin Chim Acta. 2014;34–8.
22.
Rensen S, Slaats Y, Nijhius J, Jans A, Bieghs V, Driessen A, et al. Increased hepatic myeloperoxidase activity in obese subjects with nonalcocholic steatohepatitis. Am J Pathol. 2009;1473–82.
Citation
Copyright
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Article metrics
Google scholar:
See link
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
